Proteomic studies in animal models of diabetes

Proteomics - Clinical Applications

Volumn 2, Issue 5, 2008, Pages 654-669

  Resjö, Svante ^a   Berger, Karin ^a   Fex, Malin ^b   Hansson, Ola ^b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Animal models of diabetes; Diabetic complications; Diabetic treatment; Type 1 2 diabetes

Indexed keywords

2 [(4 CHLOROPHENOXY)METHYL] 7A (3,4 DICHLOROPHENYL)TETRAHYDROPYRROLO[2,1 B]OXAZOL 5(6H) ONE; ANTIDIABETIC AGENT; APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; CALBINDIN; CHAPERONE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLITAZONE DERIVATIVE; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; GLUTAMATE DEHYDROGENASE; HAPTOGLOBIN; HYDROXYPYRUVATE REDUCTASE; INSULIN; IOXAGLIC ACID; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIRINIXIC ACID; ROSIGLITAZONE; SULFONYLUREA;

AUTOIMMUNITY; CARDIOMYOPATHY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC DIET; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIABETOGENESIS; DRUG TARGETING; DYSLIPIDEMIA; ENVIRONMENTAL FACTOR; EXPERIMENTAL ANIMAL; GEL ELECTROPHORESIS; GENE EXPRESSION REGULATION; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HEREDITY; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LIPID METABOLISM; MASS SPECTROMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ANIMALIA;

EID: 44649118613     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200780030     Document Type: Review

References (84)

1. Banting, F. G., Best, C. H., Pancreatic extracts. 1922. J. Lab. Clin. Med. 1990, 115, 254-272.
2. Zimmet, P., Alberti, K. G., Shaw, J., Global and societal implications of the diabetes epidemic. Nature 2001, 414, 782-787.
3. World Health Organization, 2006, Definition and diagnosis of diabetes mellitus and intermediate hyperglyacaemia, http://www.who.int/diabetes/ publications/Definition%20und%20diagnosis%20of%20diabetes_new.pdf.
4. Klose, J., Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals. Human-genetik 1975, 26, 231-243.
5. O'Farrell, P. H., High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 1975, 250, 4007-4021.
6. Gorg, A., Weiss, W., Dunn, M. J., Current two-dimensional electrophoresis technology for proteomics. Proteomics 2004, 4, 3665-3685.
7. Miller, I., Crawford, J., Gianazza, E., Protein stains for proteomic applications: which, when, why? Proteomics 2006, 6, 5385-5408.
8. Westermeier, R., Marouga, R., Protein detection methods in proteomics research. Biosci. Reports 2005, 25, 19-32.
9. Marengo, E., Robotti, E., Antonucci, F., Cecconi, D. et al., Numerical approaches for quantitative analysis of two-dimensional maps: a review of commercial software and home-made systems. Proteomics 2005, 5, 654-666.
10. Alban, A., David, S. O., Bjorkesten, L., Andersson, C. et al., A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 2003, 3, 36-44.
11. Unlu, M., Morgan, M. E., Minden, J. S., Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 1997, 18, 2071-2077.
12. Frohlich, T., Arnold, G. J., Proteome research based on modern liquid chromatography-tandem mass spectrometry: separation, identification and quantification. J. Neural Transm. 2006, 113, 973-994.
13. Ong, S. E., Mann, M., Stable isotope labeling by amino acids in cell culture for quantitative proteomics. Methods Mol. Biol. (Clifton NJ) 2007, 359, 37-52.
14. Ross, P. L., Huang, Y. N., Marchese, J. N., Williamson, B. et al., Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 2004, 3, 1154-1169.
15. Palagi, P. M., Walther, D., Quadroni, M., Catherinet, S. et al., MSight: an image analysis software for liquid chromatography-mass spectrometry. Proteomics 2005, 5, 2381-2384.
16. Nielsen, U. B., Geierstanger, B. H., Multiplexed sandwich assays in microarray format. J. Immunol. Methods 2004, 290, 107-120.
17. Gerber, S. A., Rush, J., Stemman, O., Kirschner, M. W., Gygi, S. P., Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl. Acad. Sci. USA 2003, 100, 6940-6945.
18. Andersen, H. U., Jorgensen, K. H., Egeberg, J., Mandrup-Poulsen, T., Nerup, J., Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans. Diabetes 1994, 43, 770-777.
19. Mandrup-Poulsen, T., Bendtzen, K., Nerup, J., Dinarello, C. A. et al., Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans. Diabetologia 1986, 29, 63-67.
20. Borg, L. A., Cagliero, E., Sandler, S., Welsh, N., Eizirik, D. L., Interleukin-1 beta increases the activity of superoxide dismutase in rat pancreatic islets. Endocrinology 1992, 130, 2851-2857.
21. Chen, M. C., Schuit, F., Pipeleers, D. G., Eizirik, D. L., IL-1beta induces serine protease inhibitor 3 (SPI-3) gene expression in rat pancreatic beta-cells. Detection by differential display of messenger RNA. Cytokine 1999, 11, 856-862.
22. Andersen, H. U., Fey, S. J., Larsen, P. M., Nawrocki, A. et al., Interleukin-1beta induced changes in the protein expression of rat islets: a computerized database. Electrophoresis 1997, 18, 2091-2103.
23. Larsen, P. M., Fey, S. J., Larsen, M. R., Nawrocki, A. et al., Proteome analysis of interleukin-1beta-induced changes in protein expression in rat islets of Langerhans. Diabetes 2001, 50, 1056-1063.
24. Christensen, U. B., Larsen, P. M., Fey, S. J., Andersen, H. U. et al., Islet protein expression changes during diabetes development in islet syngrafts in BB-DP rats and during rejection of BB-DP islet allografts. Autoimmunity 2000, 32, 1-15.
25. Sparre, T., Christensen, U. B., Mose Larsen, P., Fey, S. J. et al., IL-1beta induced protein changes in diabetes prone BB rat islets of Langerhans identified by proteome analysis. Diabetologia 2002, 45, 1550-1561.
26. Sparre, T., Christensen, U. B., Gotfredsen, C. F., Larsen, P. M. et al., Changes in expression of IL-1 beta influenced proteins in transplanted islets during development of diabetes in diabetes-prone BB rats. Diabetologia 2004, 47, 892-908.
27. Nerup, J., Mandrup-Poulsen, T., Helqvist, S., Andersen, H. U. et al., On the pathogenesis of IDDM. Diabetologia 1994, 37 Suppl 2 , S82-89.
28. Mandrup-Poulsen, T., The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 1996, 39, 1005-1029.
29. Christensen, U. B., Larsen, P. M., Fey, S., Karlsen, A. E. et al., Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats. Autoimmunity 2006, 39, 315-321.
30. D'Hertog, W., Mathieu, C., Overbergh, L., Type 1 diabetes: entering the proteomic era. Expert Rev. Proteomics 2006, 3, 223-236.
31. Sparre, T., Larsen, M. R., Heding, P. E., Karlsen, A. E. et al., Unraveling the pathogenesis of type 1 diabetes with proteomics: present and future directions. Mol. Cell. Proteomics 2005, 4, 441-457.
32. Diao, W. F., Chen, W. Q., Wu, Y., Liu, P. et al., Serum, liver, and kidney proteomic analysis for the alloxan-induced type I diabetic mice after insulin gene transfer of naked plasmid through electroporation. Proteomics 2006, 6, 5837-5845.
33. Newsholme, P., Brennan, L., Rubi, B., Maechler, P., New insights into amino acid metabolism, beta-cell function and diabetes. Clin. Sci. (Lond) 2005, 108, 185-194.
34. Carobbio, S., Ishihara, H., Fernandez-Pascual, S., Bartley, C. et al., Insulin secretion profiles are modified by over-expression of glutamate dehydrogenase in pancreatic islets. Diabetologia 2004, 47, 266-276.
35. Miyata, V., Koga, S., Ibayashi, H., Alterations in plasma levels of apolipoprotein A-IV in various clinical entities. Gastroenterol. Jpn. 1986, 21, 479-485.
36. Quilliot, D., Walters, E., Guerci, B., Fruchart, J. C. et al., Effect of the inflammation, chronic hyperglycemia, or malabsorption on the apolipoprotein A-IV concentration in type 1 diabetes mellitus and in diabetes secondary to chronic pancreatitis. Metabolism 2001, 50, 1019-1024.
37. Verges, B., Apolipoprotein A-IV in diabetes mellitus. Diabete Metab. 1995, 21, 99-105.
38. Tseng, C. F., Lin, C. C., Huang, H. Y., Liu, H. C., Mao, S. J., Antioxidant role of human haptoglobin. Proteomics 2004, 4, 2221-2228.
39. McMillan, D. E., Increased levels of acute-phase serum proteins in diabetes. Metabolism 1989, 38, 1042-1046.
40. Yang, M., Liu, W., Wang, C. Y., Liu, T. et al., Proteomic analysis of differential protein expression in early process of pancreatic regeneration in pancreatectomized rats. Acta Pharmacol. Sin. 2006, 27, 568-578.
41. Chafel, M. M., Shen, W., Matsudaira, P., Sequential expression and differential localization of I-, L-, and T-fimbrin during differentiation of the mouse intestine and yolk sac. Dev. Dyn. 1995, 203, 141-151.
42. Pagan, R., Martin, I., Alonso, A., Llobera, M., Vilaro, S., Vimentin filaments follow the preexisting cytokeratin network during epithelial-mesenchymal transition of cultured neonatal rat hepatocytes. Exp. Cell Res. 1996, 222, 333-344.
43. Casaroli-Marano, R. P., Pagan, R., Vilaro, S., Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 1999, 40, 2062-2072.
44. Zhao, H., Cao, Y., Grunz, H., Expression of Xenopus L-arginine:glycine amidinotransferase (XAT) during early embryonic development. Dev. Genes Evol. 2001, 211, 358-360.
45. Gerling, I. C., Singh, S., Lenchik, N. I., Marshall, D. R., Wu, J., New data analysis and mining approaches identify unique proteome and transcriptome markers of susceptibility to autoimmune diabetes. Mol. Cell. Proteomics 2006, 5, 293-305.
46. Anderson, M. S., Bluestone, J. A., The NOD mouse: a model of immune dysregulation. Ann. Rev. Immunol. 2005, 23, 447-485.
47. Lenchik, N. I., Desiderio, D. M., Gerling, I. C., Two-dimensional gel electrophoresis characterization of the mouse leukocyte proteome, using a tri-reagent for protein extraction. Proteomics 2005, 5, 2202-2209.
48. Sanchez, J. C., Chiappe, D., Converset, V., Hoogland, C. et al., The mouse SWISS-2D PAGE database: a tool for proteomics study of diabetes and obesity. Proteomics 2001, 1, 136-163.
49. Winzell, M. S., Ahren, B., The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 2004, 53 Suppl 3, S215-219.
50. Fex, M., Nitert, M. D., Wierup, N., Sundler, F. et al., Enhanced mitochondrial metabolism may account for the adaptation to insulin resistance in islets from C57BL/6J mice fed a high-fat diet. Diabetologia 2007, 50, 74-83.
51. Morand, J. P., Macri, J., Adeli, K., Proteomic profiling of hepatic endoplasmic reticulum-associated proteins in an animal model of insulin resistance and metabolic dyslipidemia. J. Biol. Chem. 2005, 280, 17626-17633.
52. Sparre, T., Reusens, B., Cherif, H., Larsen, M. R. et al., Intrauterine programming of fetal islet gene expression in rats-effects of maternal protein restriction during gestation revealed by proteome analysis. Diabetologia 2003, 46, 1497-1511.
53. Matsumura, T., Suzuki, T., Kada, N., Aizawa, K. et al., Differential serum proteomic analysis in a model of metabolic disease. Biochem. Biophys. Res. Commun. 2006, 351, 965-971.
54. Budde, P., Schulte, I., Appel, A., Neitz, S. et al., Peptidomics biomarker discovery in mouse models of obesity and type 2 diabetes. Comb. Chem. High Throughput Screen. 2005, 8, 775-781.
55. Barglow, K. T., Cravatt, B. F., Discovering disease-associated enzymes by proteome reactivity profiling. Chem. Biol. 2004, 11, 1523-1531.
56. Xue, H. H., Fujie, M., Sakaguchi, T., Oda, T. et al., Flux of the L-serine metabolism in rat liver. The predominant contribution of serine dehydratase. J. Biol. Chem. 1999, 274, 16020-16027.
57. Xue, H. H., Sakaguchi, T., Fujie, M., Ogawa, H., Ichiyama, A., Flux of the L-serine metabolism in rabbit, human, and dog livers. Substantial contributions of both mitochondrial and peroxisomal serine:pyruvate/ alanine:glyoxylate aminotransferase. J. Biol. Cchem. 1999, 274, 16028-16033.
58. Grimsrud, P.A., Picklo Sr, M. J., Griffin, T. J., Bernlohr, D. A., Carbonylation of adipose proteins in obesity and insulin resistance: Identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal. Mol. Cell. Proteomics 2007.
59. Hansson, O., Strom, K., Guner, N., Wierup, N. et al., Inflammatory response in white adipose tissue in the non-obese hormone-sensitive lipase null mouse model. J. Proteome Res. 2006, 5, 1701-1710.
60. Turko, I. V., Murad, F., Quantitative protein profiling in heart mitochondria from diabetic rats. J. Biol. Cchem. 2003, 278, 35844-35849.
61. Gehanne, S., Cecconi, D., Carboni, L., Righetti, P. G. et al., Quantitative analysis of two-dimensional gel-separated proteins using isotopically marked alkylating agents and matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun. Mass Spectrom. 2002, 16, 1692-1698.
62. Sechi, S., A method to identify and simultaneously determine the relative quantities of proteins isolated by gel electrophoresis. Rapid Commun. Mass Spectrom. 2002, 16, 1416-1424.
63. Shen, X., Zheng, S., Thongboonkerd, V., Xu, M. et al., Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes. Am. J. Physiol. Endocrinol. Metab. 2004, 287, E896-905.
64. Epstein, P. N., Overbeek, P. A., Means, A. R., Calmodulin-induced early-onset diabetes in transgenic mice. Cell 1989, 58, 1067-1073.
65. Hamblin, M., Friedman, D. B., Hill, S., Caprioli, R. M. et al., Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy. J. Mol. Cell. Cardiol. 2007.
66. Zheng, S., Noonan, W. T., Metreveli, N. S., Coventry, S. et al., Development of late-stage diabetic nephropathy in OVE26 diabetic mice. Diabetes 2004, 53, 3248-3257.
67. Carlson, E. C., Audette, J. L., Klevay, L. M., Nguyen, H., Epstein, P. N., Ultrastructural and functional analyses of nephropathy in calmodulin-induced diabetic transgenic mice. Anat. Rec. 1997, 247, 9-19.
68. Thongboonkerd, V., Barati, M. T., McLeish, K. R., Benarafa, C. et al., Alterations in the renal elastin-elastase system in type 1 diabetic nephropathy identified by proteomic analysis. J. Am. Soc. Nephrol. 2004, 15, 650-662.
69. Thongboonkerd, V., Zheng, S., McLeish, K. R., Epstein, P. N., Klein, J. B., Proteomic Identification and Immunolocalization of Increased Renal Calbindin-D28k Expression in OVE26 Diabetic Mice. Rev. Diabet. Stud. 2005, 2, 19-26.
70. Sooy, K., Kohut, J., Christakos, S., The role of calbindin and 1,25 dihydroxyvitamin D3 in the kidney. Curr. Opin. Nephrol. Hypertens. 2000, 9, 341-347.
71. Liu, S. Q., Zhang, Y. Y., Xie, X. Y., Hu, W. M, et al., Application of two-dimensional electrophoresis in the research of retinal proteins of diabetic rat. Cell. Mol. Immunol. 2007, 4, 65-70.
72. Liu, S. Q., Kang, J., Li, C. J., Tang, E. J. et al., Differences in expression of retinal proteins between diabetic and normal rats. World J. Gastroenterol. 2007, 13, 2118-2124.
73. Quin, G. G., Len, A. C., Billson, F. A., Gillies, M. C., Proteome map of normal rat retina and comparison with the proteome of diabetic rat retina: new insight in the pathogenesis of diabetic retinopathy. Proteomics 2007, 7, 2636-2650.
74. Staels, B., Fruchart, J. C., Therapeutic roles of peroxisome proliferator-activated receptor agonists. Diabetes 2005, 54, 2460-2470.
75. Edvardsson, U., Alexandersson, M. Brockenhuus von Lowenhielm, H., Nystrom, A. C. et al., A proteome analysis of livers from obese (ob/ob) mice treated with the peroxisome proliferator WY14,643. Electrophoresis 1999, 20, 935-942.
76. Edvardsson, U., Bergstrom, M., Alexandersson, M., Bamberg, K. et al., Rosiglitazone (BRL49653), a PPARgamma-selective agonist, causes peroxisome proliferator-like liver effects in obese mice. J. Lipid Res. 1999, 40, 1177-1184.
77. Edvardsson, U., von Lowenhielm, H. B., Panfilov, O., Nystrom, A. C. et al., Hepatic protein expression of lean mice and obese diabetic mice treated with peroxisome proliferator-activated receptor activators. Proteomics 2003, 3, 468-478.
78. Sanchez, J. C., Converset, V., Nolan, A., Schmid, G. et al., Effect of rosiglitazone on the differential expression of diabetes-associated proteins in pancreatic islets of C57BI/6 lep/lep mice. Mol. Cell. Proteomics 2002, 1, 509-516.
79. Sanchez, J. C., Converset, V., Nolan, A., Schmid, G. et al., Effect of rosiglitazone on the differential expression of obesity and insulin resistance associated proteins in lep/lep mice. Proteomics 2003, 3, 1500-1520.
80. Arce, A., Aicher, L., Wahl, D., Anderson, N. L. et al., Changes in the liver protein pattern of female Wistar rats treated with the hypoglycemic agent SDZ PGU 693. Life Sci. 1998, 63, 2243-2250.
81. Waters, K. M., Pounds, J. G., Thrall, B. D., Data merging for integrated microarray and proteomic analysis. Briefings in functional genomics & proteomics 2006, 5, 261-272.
82. Meunier, B., Bouley, J., Piec, I., Bernard, C. et al., Data analysis methods for detection of differential protein expression in two-dimensional gel electrophoresis. Anal. Biochem. 2005, 340, 226-230.
83. Karp, N. A., McCormick, P. S., Russell, M. R., Lilley, K. S., Experimental and statistical considerations to avoid false conclusions in proteomic studies using differential in-gel electrophoresis. Mol. Cell. Proteomics 2007.
84. Engkilde, K., Jacobsen, S., Sondergaard, I., Multivariate data analysis of proteome data. Methods Mol. Biol. (Clifton, NJ) 2007, 355, 195-210.